Published in Eur Radiol on March 20, 2010
Indeterminate adnexal masses at ultrasound: effect of MRI imaging findings on diagnostic thinking and therapeutic decisions. Eur Radiol (2010) 0.93
Ovarian tumor characterization and classification using ultrasound-a new online paradigm. J Digit Imaging (2013) 0.80
Mucinous borderline ovarian tumor: a case report with diagnostic insights on ultrasound findings. J Ultrason (2016) 0.75
GyneScan: an improved online paradigm for screening of ovarian cancer via tissue characterization. Technol Cancer Res Treat (2013) 0.75
A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol (1990) 3.58
Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol (1991) 2.44
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer (2002) 1.77
A morphology index based on sonographic findings in ovarian cancer. Gynecol Oncol (1993) 1.76
Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int (2007) 1.61
Distinguishing the benign and malignant adnexal mass: an external validation of prognostic models. Gynecol Oncol (2001) 1.55
Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol (1996) 1.44
The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol (2003) 1.22
Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses. Ultrasound Obstet Gynecol (1999) 1.19
Accuracy of transvaginal sonography and rectal endoscopic sonography in the diagnosis of deep infiltrating endometriosis. Ultrasound Obstet Gynecol (2007) 1.13
Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. Gynecol Oncol (1989) 1.09
Management of adnexal mass. Evid Rep Technol Assess (Full Rep) (2006) 1.08
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening. BJOG (2000) 1.03
The role of magnetic resonance imaging and ultrasound in patients with adnexal masses. Clin Radiol (2005) 1.02
Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. Radiology (2002) 0.98
The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int (2008) 0.98
The efficacy of a sonographic morphology index in identifying ovarian cancer: a multi-institutional investigation. Gynecol Oncol (1994) 0.96
Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecol Oncol (2000) 0.94
Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses. Ultrasound Obstet Gynecol (1999) 0.94
Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study. Ultrasound Obstet Gynecol (1997) 0.93
Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. Am J Obstet Gynecol (1994) 0.92
Ovarian ultrasound image analysis: follicle segmentation. IEEE Trans Med Imaging (1998) 0.87
Predicting ovarian malignancy: application of artificial neural networks to transvaginal and color Doppler flow US. Radiology (1999) 0.86
Sonographic prediction of malignancy in adnexal masses using an artificial neural network. Br J Obstet Gynaecol (1999) 0.85
An automatic approach for morphological analysis and malignancy evaluation of ovarian masses using B-scans. Ultrasound Med Biol (2003) 0.83
Combined transvaginal B-mode and color Doppler sonography for differential diagnosis of ovarian tumors: results of a multivariate logistic regression analysis. Gynecol Oncol (2000) 0.82
Complex pelvic mass as a target of evaluation of vessel distribution by color Doppler sonography for the diagnosis of adnexal malignancies: results of a multicenter European study. J Ultrasound Med (2002) 0.80
Multiresolution texture segmentation with application to diagnostic ultrasound images. IEEE Trans Med Imaging (1993) 0.80
Transvaginal color Doppler sonography in adnexal masses: which parameter performs best? Ultrasound Obstet Gynecol (1996) 0.78
Knowledge-based system ADNEXPERT to assist the sonographic diagnosis of adnexal tumors. Methods Inf Med (1997) 0.78
The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Int J Gynaecol Obstet (2003) 0.77
Diagnosis of pelvic masses with transabdominal color Doppler, CA 125 and ultrasonography. Acta Obstet Gynecol Scand (1995) 0.76
Semiautomated segmentation of ovarian follicular ultrasound images using a knowledge-based algorithm. Ultrasound Med Biol (1998) 0.76
Value of ultrasound and magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses. Anticancer Res (2002) 0.75
Hair as a sonographic marker of ovarian teratomas: improved identification using transvaginal sonography and simulation model. J Clin Ultrasound (1991) 0.75
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med (2004) 30.26
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ (2012) 4.79
Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme. BJU Int (2012) 4.01
Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol (2008) 3.75
Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol (2006) 3.70
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol (2008) 3.49
'Environment' in cancer causation and etiological fraction: limitations and ambiguities. Carcinogenesis (2007) 3.20
Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database. Lancet Oncol (2013) 2.91
Relevance of random biopsy at the transformation zone when colposcopy is negative. Obstet Gynecol (2014) 2.71
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2005) 2.47
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer (2011) 2.43
2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol (2012) 2.32
Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer (2008) 2.29
Causes of death among Belgian professional military radar operators: a 37-year retrospective cohort study. Int J Cancer (2009) 2.17
Clinical relevance of objectifying colposcopy. Arch Gynecol Obstet (2014) 2.03
Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos Int (2003) 1.91
Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. J Natl Cancer Inst (2013) 1.90
Evaluation of the VITOM in digital high-definition video exocolposcopy. J Low Genit Tract Dis (2011) 1.87
Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res (2008) 1.83
A new approach to preserve fertility by using a coated nitinol stent in a patient with recurrent cervical stenosis. Fertil Steril (2006) 1.78
Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol (2008) 1.77
Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol (2007) 1.74
Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer (2003) 1.73
Laparoscopic-assisted radical vaginal hysterectomy (LARVH): prospective evaluation of 200 patients with cervical cancer. Gynecol Oncol (2003) 1.70
A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer (2005) 1.70
TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol (2007) 1.70
Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy? Gynecol Oncol (2005) 1.68
Incremental detection rate of prostate cancer by real-time elastography targeted biopsies in combination with a conventional 10-core biopsy in 1024 consecutive patients. BJU Int (2014) 1.66
Solid neuroendocrine carcinomas of the breast: metastases or primary tumors? Breast Cancer Res Treat (2010) 1.63
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer (2012) 1.63
Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int (2007) 1.61
Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women. Cancer Causes Control (2010) 1.61
How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. Am J Obstet Gynecol (2008) 1.57
Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2008) 1.57
Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res (2004) 1.53
Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer (2007) 1.50
HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol (2009) 1.48
New paradigm for prevention of cervical cancer. Eur J Obstet Gynecol Reprod Biol (2006) 1.48
Managing older patients with colorectal cancer. J Clin Oncol (2007) 1.47
An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype. Infect Immun (2008) 1.45
Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol Oncol (2009) 1.44
Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer (2006) 1.44
Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes. J Mol Diagn (2011) 1.41
Laparoscopic pelvic lymphadenectomy in 32 pregnant patients with cervical cancer: rationale, description of the technique, and outcome. Int J Gynecol Cancer (2014) 1.41
Vaginal reconstruction after extended radical pelvic surgery for cancer: comparison of two techniques. Plast Reconstr Surg (2002) 1.40
Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer (2004) 1.40
Cyclodimerization of an oxoboryl complex induced by trans ligand abstraction. Angew Chem Int Ed Engl (2010) 1.39
Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst (2013) 1.38
Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years. Vaccine (2008) 1.35
Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer (2007) 1.33
Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol (2005) 1.32
The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res (2008) 1.30
Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha. Mol Cancer (2008) 1.29
Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. J Natl Cancer Inst (2013) 1.28
Differentiation of phyllodes breast tumors from fibroadenomas on MRI. AJR Am J Roentgenol (2005) 1.27
Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer. Gynecol Oncol (2006) 1.26
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. J Clin Microbiol (2006) 1.24
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer (2013) 1.24
Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. J Bone Joint Surg Am (2003) 1.24
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer. Clin Cancer Res (2002) 1.22
Risk assessment to guide the prevention of cervical cancer. J Low Genit Tract Dis (2008) 1.21
Secular trends in breast cancer mortality in five East Asian populations: Hong Kong, Japan, Korea, Singapore and Taiwan. Cancer Sci (2010) 1.21
Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. Am J Obstet Gynecol (2005) 1.20
A melanoma epidemic in Iceland: possible influence of sunbed use. Am J Epidemiol (2010) 1.15
Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol (2009) 1.15
Electron-precise coordination modes of boron-centered ligands. Chem Rev (2010) 1.14
Cumulative 5-year diagnoses of CIN2, CIN3 or cervical cancer after concurrent high-risk HPV and cytology testing in a primary screening setting. Int J Cancer (2005) 1.14
Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. Cancer Epidemiol Biomarkers Prev (2009) 1.13
Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer. J Clin Oncol (2003) 1.13
Laparoscopic staging compared with imaging techniques in the staging of advanced cervical cancer. Gynecol Oncol (2002) 1.12
Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling. BMC Infect Dis (2014) 1.12
Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients. J Cancer Res Clin Oncol (2003) 1.10
Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer. J Pathol (2005) 1.10
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project. Int J Cancer (2014) 1.10
Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer? Gynecol Oncol (2005) 1.10
RE: Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom. Int J Cancer (2012) 1.09
Small-bowel infarction from disseminated aspergillosis. Dis Colon Rectum (2004) 1.08
Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol (2006) 1.08
Intraductal papillomas of the breast: diagnosis and management of 151 patients. Breast (2011) 1.08
Strength/endurance training versus endurance training in congestive heart failure. Med Sci Sports Exerc (2002) 1.08
Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene (2003) 1.07
A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer (2013) 1.07
Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol (2006) 1.06
Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Gynecol Oncol (2004) 1.06
Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities. J Womens Health (Larchmt) (2011) 1.04
Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3). Int J Cancer (2007) 1.04
Reviews on sun exposure and artificial light and melanoma. Prog Biophys Mol Biol (2011) 1.02
Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur Radiol (2002) 1.02
Cancer survival statistics should be viewed with caution. Lancet Oncol (2007) 1.02
Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci (2009) 1.02
Prevalence of main cancer lifestyle risk factors in Europe in 2000. Eur J Cancer (2010) 1.01
Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years. Hum Vaccin (2011) 1.01
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. Epidemiol Prev (2012) 1.01
Inner border--a specific and significant colposcopic sign for moderate or severe dysplasia (cervical intraepithelial neoplasia 2 or 3). J Low Genit Tract Dis (2009) 1.01
Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™). BJU Int (2011) 1.01